OP Asset Management Ltd Invests $1.26 Million in OPKO Health, Inc. $OPK

OP Asset Management Ltd bought a new position in shares of OPKO Health, Inc. (NASDAQ:OPK) during the first quarter, Holdings Channel.com reports. The fund bought 1,102,254 shares of the biotechnology company’s stock, valued at approximately $1,257,000.

Other large investors have also recently bought and sold shares of the company. Swiss Life Asset Management Ltd acquired a new stake in OPKO Health in the 3rd quarter worth $30,000. Zacks Investment Management acquired a new position in shares of OPKO Health during the fourth quarter valued at about $27,000. StoneX Group Inc. acquired a new position in shares of OPKO Health during the fourth quarter valued at about $27,000. Apella Capital LLC bought a new stake in shares of OPKO Health in the first quarter valued at about $34,000. Finally, Cibc World Markets Corp bought a new stake in shares of OPKO Health in the fourth quarter valued at about $34,000. 64.63% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on the company. Barrington Research downgraded OPKO Health from an “outperform” rating to a “market perform” rating in a research report on Wednesday, April 29th. Weiss Ratings raised OPKO Health from a “sell (e+)” rating to a “sell (d-)” rating in a report on Monday, May 18th. Finally, Wall Street Zen upgraded OPKO Health from a “sell” rating to a “hold” rating in a research report on Saturday, June 6th. One analyst has rated the stock with a Strong Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, OPKO Health has a consensus rating of “Hold” and a consensus target price of $1.55.

OPKO Health Trading Down 1.3%

Shares of OPK stock opened at $1.51 on Tuesday. The firm has a fifty day moving average of $1.30 and a 200-day moving average of $1.26. The stock has a market cap of $1.14 billion, a price-to-earnings ratio of -5.59 and a beta of 1.49. OPKO Health, Inc. has a 52-week low of $0.98 and a 52-week high of $1.61. The company has a debt-to-equity ratio of 0.28, a quick ratio of 3.17 and a current ratio of 3.61.

OPKO Health (NASDAQ:OPK) last posted its earnings results on Tuesday, April 28th. The biotechnology company reported ($0.07) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.07). OPKO Health had a negative net margin of 36.63% and a negative return on equity of 16.78%. The business had revenue of $124.20 million for the quarter, compared to analysts’ expectations of $130.51 million. During the same quarter in the previous year, the firm posted ($0.10) earnings per share. The firm’s revenue for the quarter was down 17.1% on a year-over-year basis. On average, equities research analysts forecast that OPKO Health, Inc. will post -0.29 earnings per share for the current fiscal year.

About OPKO Health

OPKO Health, Inc (NASDAQ:OPK) is a diversified, global healthcare company headquartered in Miami, Florida, with a focus on diagnostics, pharmaceuticals and biologics development. The company operates two main business segments—Laboratory Services and Pharma Services & Products—driven by its mission to advance patient care through innovation in testing and targeted therapies.

In its Laboratory Services segment, OPKO leverages BioReference Laboratories, one of the largest full-service commercial labs in the United States.